Hypothesis · not a trading signal
Q2 2026 · Published 2026-07-16 · Source checked 2026-09-06
- 01 / What the issuer reported
- US-dollar revenue was $40.20bn; gross margin 67.7%; quarterly EPS was US$4.31 per ADR.
- 02 / Our hypothesis — not established alpha
- Leading-node yield and packaging can capture value across competing chip designers; geographic disruption remains a separate tail risk.
- 03 / What to measure next
- Node mix, utilization, packaging capacity, overseas-fab margin impact, capex and monthly sales with seasonal comparisons.
- 04 / What would challenge the thesis
- Reassess after sustained yield/ramp failure or lower utilization with rising capital intensity; analyze disruption separately.
- 05 / Appropriate valuation method
- Cycle-aware DCF in reporting currency, then consistent ADR/FX conversion; no arbitrary catastrophe probability.
- 06 / Still missing
- Missing: capacity/yield scenarios, FX bridge and explicit supply-disruption stress.
No measured consensus gap or approved price target. A familiar good business can still be an expensive stock.